GSE143212 0 V 3 BLEOMYCIN MOUSE UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE143212 0 V 3 BLEOMYCIN MOUSE UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE143212 0 V 3 BLEOMYCIN MOUSE UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE143212 0 V 3 BLEOMYCIN MOUSE UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE143212 0 V 3 BLEOMYCIN MOUSE UP.

Results found

Linked to

 

Label

Description

 

Gene

valyl-tRNA synthetase 1

Gene

mitochondrial ribosomal protein L45

Gene

cytokine receptor like factor 2

Gene

tripartite motif containing 15

Gene

lymphocyte antigen 6 family member G5B

Gene

H3 clustered histone 1

Gene

olfactory receptor family 14 subfamily J member 1

Gene

small integral membrane protein 40

Gene

corin, serine peptidase

Gene

mitochondrial rRNA methyltransferase 3

  • Gene

    valyl-tRNA synthetase 1


  • Gene

    mitochondrial ribosomal protein L45


  • Gene

    cytokine receptor like factor 2


  • Gene

    tripartite motif containing 15


  • Gene

    lymphocyte antigen 6 family member G5B


  • Gene

    H3 clustered histone 1


  • Gene

    olfactory receptor family 14 subfamily J member 1


  • Gene

    small integral membrane protein 40


  • Gene

    corin, serine peptidase


  • Gene

    mitochondrial rRNA methyltransferase 3

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.